ISRCTN14751416已完成不适用
Clopidose trial
Geneva University Hospital (Switzerland)0 个研究点目标入组 150 人开始时间: 2006年1月27日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Cardiovascular outpatients on 75 mg/day clopidogrel
排除标准
- •Anticoagulation
研究者
相似试验
进行中（未招募）
1 期
First trial on clobetasol propionate 0.05% and betamethasone dipropionate 0.05% plus salicilic acid 3% in the treatment of vulvar lichen sclerosus: comparison of efficacy and tolerabilityichen sclerosus vulvareMedDRA version: 20.0Level: PTClassification code 10024434Term: Lichen sclerosusSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2015-004298-33-ITAZIENDA OSPEDALIERO-UNIVERSITARIA PISANA66
招募中
不适用
A Probiotic and Magnesium orotate combination for the treatment of depression.Mental Health - DepressionAlternative and Complementary Medicine - Other alternative and complementary medicineDepressionACTRN12617000419369Medlab Clinical LTD130
已完成
不适用
The Neurocognitive effects of Lacprodan(Registered Trademark) PL-20 in elderly participants with age-associated memory impairment.Age-associated Memory Impairment (AAMI)Mental Health - Studies of normal psychology, cognitive function and behaviourACTRN12613000347763Swinburne University of Technology138
进行中（未招募）
1 期
A Study to Test the Effects of Exenatide Once Weekly on Cardiovascular Outcomes in Patients with Type 2 DiabetesType 2 diabetes mellitusMedDRA version: 20.0Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2010-021069-63-SKAmylin Pharmaceuticals, LLC14,000
已完成
3 期
A randomized, placebo, controlled clinical trial to evaluate cardiovascular outcomes after treatment with Exenatide Once Weekly in patients with type 2 diabetes mellitusnon-insulin dependent diabetesType 2 diabetes mellitus10018424NL-OMON41366Amylin Pharmaceuticals, LLC204